◄ back to all posts
Financial data and stock pages provided by
Fintel.io
A Vaccine Won’t Cure The 20-Year “Widow-Maker” Trade
Nov 30, 2020
#WhatYouMissed On RIA This Week: 11-27-20
Nov 27, 2020
David Robertson: Growth & Inflation Remain Quiescent
Nov 27, 2020
◄ back to all posts
DCF: Dreyfus Alcentra Glb Cr Inc 2024 Stock
Written by | Jul 6, 2018
Print Friendly| Valuation | |
|---|---|
| Market Cap ($M) | 127.49 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | n/a |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | n/a |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 7.50 | 21.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,249 | 50,800 | 33.95 | |
| 8,477 | 18,000 | 47.09 | |
| 5,408 | 30,200 | 17.91 | |
| 14,129 | 47,500 | 29.75 | |
(click for more detail) |
|||
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
